Investigation of the activity of vidofludimus calcium, a novel, orally available, small molecule inhibitor of dihydroorotate dehydrogenase, as a treatment for primary sclerosing cholangitis (PSC)

Project: Research project

StatusActive
Effective start/end date9/22/186/30/20

Funding

  • HHS: National Institutes of Health (NIH): $395,116.00